Mr. Eugene Cherny reports

CHEELCARE ANNOUNCES MEDICARE AND MEDICAID SERVICES REIMBURSEMENT APPROVAL FOR COMPANION POWER ASSIST DEVICE, EXPANDING U.S. MARKET ACCESS

Cheelcare Inc. has received pricing, data analysis and coding verification for the Companion power-assist device, confirming reimbursement eligibility.

Cheelcare currently is represented by a growing network of over 300 authorized dealers throughout the United States. Historically, adoption of Companion within this network has been primarily concentrated within Veterans Affairs, Vocational Rehab and Workers Compensation programs due to the absence of Medicare and Medicaid reimbursement. This reimbursement represents a significantly larger addressable market, and the company expects this approval to accelerate sales activity across its existing U.S. dealer footprint.

"PDAC approval of a product is a critical step that most DME dealers require," said Allan Boyd, Cheelcare's vice-president of growth. "This approval confirms that dealers may bill Medicare for Companion under HCPCS Code E0986, which is expected to reduce financial barriers to providing medically necessary equipment for users who would otherwise be required to pay out-of-pocket. This makes our technology more accessible to end-users who need it and gives therapists the ability to prescribe it without funding-related constraints."

"This approval marks an important milestone for Cheelcare," said Eugene Cherny, chief executive officer of Cheelcare. "We believe we have a best-in-class product, have built a strong U.S. dealer network, and have invested ahead of this milestone to enhance our product, strengthen our quality systems and expand manufacturing capacity at our new 16,000-square-foot facility. Together, these efforts position us well to capitalize on the growth and demand we expect to see as a result of this major development."

The company also noted recent commercial momentum for Companion, with record assisted-device sales achieved in November and December, 2025, reflecting growing demand within the U.S. market ahead of broader Medicare and Medicaid reimbursement availability.

About Cheelcare Inc.

Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power-assist devices to the groundbreaking Curio robotic complex-rehab power wheelchair, Cheelcare combines engineering excellence with human-centred design to improve quality of life.

We seek Safe Harbor.